Literature DB >> 10618289

Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.

R Vemulapalli1, S Cravero, C L Calvert, T E Toth, N Sriranganathan, S M Boyle, O L Rossetti, G G Schurig.   

Abstract

Using the shuttle vector pMCO2 and the vaccinia virus wild-type WR strain, we constructed a recombinant virus expressing an 18-kDa outer membrane protein of Brucella abortus. BALB/c mice inoculated with this virus produced 18-kDa protein-specific antibodies, mostly of immunoglobulin G2a isotype, and in vitro stimulation of splenocytes from these mice with purified maltose binding protein-18-kDa protein fusion resulted in lymphocyte proliferation and gamma interferon production. However, these mice were not protected against a challenge with the virulent strain B. abortus 2308. Disruption of the 18-kDa protein's gene in vaccine strain B. abortus RB51 did not affect either the strain's protective capabilities or its in vivo attenuation characteristics. These observations suggest that the 18-kDa protein plays no role in protective immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618289      PMCID: PMC95834          DOI: 10.1128/CDLI.7.1.114-118.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice.

Authors:  E Latimer; J Simmers; N Sriranganathan; R M Roop; G G Schurig; S M Boyle
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

2.  E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.

Authors:  M W Carroll; B Moss
Journal:  Biotechniques       Date:  1995-09       Impact factor: 1.993

3.  Transformation of Brucella species with suicide and broad host-range plasmids.

Authors:  J R McQuiston; G G Schurig; N Sriranganathan; S M Boyle
Journal:  Methods Mol Biol       Date:  1995

4.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

6.  Selective humoral immune response of Balb/C mice to Brucella abortus proteins expressed by vaccinia virus recombinants.

Authors:  T E Toth; J A Cobb; S M Boyle; R M Roop; G G Schurig
Journal:  Vet Microbiol       Date:  1995-07       Impact factor: 3.293

Review 7.  Brucellosis.

Authors:  I Z Trujillo; A N Zavala; J G Caceres; C Q Miranda
Journal:  Infect Dis Clin North Am       Date:  1994-03       Impact factor: 5.982

8.  Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Authors:  M P Jiménez de Bagüés; P H Elzer; S M Jones; J M Blasco; F M Enright; G G Schurig; A J Winter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus.

Authors:  A Tibor; E Saman; P de Wergifosse; A Cloeckaert; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine.

Authors:  L B Tabatabai; G W Pugh
Journal:  Vaccine       Date:  1994-08       Impact factor: 3.641

View more
  21 in total

1.  Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice.

Authors:  Shailendra Kumar Verma; Shikha Jain; Subodh Kumar
Journal:  World J Microbiol Biotechnol       Date:  2012-04-22       Impact factor: 3.312

2.  Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.

Authors:  Morteza Abkar; Abbas Sahebghadam Lotfi; Jafar Amani; Khadijeh Eskandari; Mehdi Fasihi Ramandi; Jafar Salimian; Gholamreza Nikbakht Brujeni; Saeed Alamian; Mehdi Kamali; Hamid Koushki
Journal:  Vet Res Commun       Date:  2015-09-22       Impact factor: 2.459

3.  A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.

Authors:  Juliana Cassataro; Carlos A Velikovsky; Silvia de la Barrera; Silvia M Estein; Laura Bruno; Raúl Bowden; Karina A Pasquevich; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.

Authors:  Neelima Sanakkayala; Anna Sokolovska; Jatinder Gulani; Harm Hogenesch; Nammalwar Sriranganathan; Stephen M Boyle; Gerhardt G Schurig; Ramesh Vemulapalli
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

5.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Authors:  R Vemulapalli; Y He; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice.

Authors:  Wenpeng Gu; Xin Wang; Haiyan Qiu; Buyun Cui; Shiwen Zhao; Han Zheng; Yuchun Xiao; Junrong Liang; Ran Duan; Huaiqi Jing
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

9.  Effect of omp10 or omp19 deletion on Brucella abortus outer membrane properties and virulence in mice.

Authors:  Anne Tibor; Valérie Wansard; Valery Bielartz; Rose-May Delrue; Isabelle Danese; Patrick Michel; Karl Walravens; Jacques Godfroid; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Authors:  Karina A Pasquevich; Silvia M Estein; Clara García Samartino; Clara García Samartino; Astrid Zwerdling; Lorena M Coria; Paula Barrionuevo; Carlos A Fossati; Guillermo H Giambartolomei; Juliana Cassataro
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.